Fibromyalgia does not have officially recognized medical stages the way cancer or kidney disease does. No medical organization has established a formal staging system. However, a large study of over 2,500 fibromyalgia patients published in the Journal of Pain Research identified four distinct classes of the condition that reflect increasing severity, and many people experience a recognizable pattern of progression from localized pain to widespread, multi-system symptoms.
Why There Are No Official Stages
Fibromyalgia has no blood test, imaging scan, or biomarker that can confirm a diagnosis or measure how far the condition has progressed. Diagnosis relies on symptom-based criteria from the American College of Rheumatology: a combination of a widespread pain index score and a symptom severity score. Because there’s no objective way to measure tissue damage or disease advancement (unlike, say, joint erosion in rheumatoid arthritis), a formal staging system hasn’t been established.
That said, the condition clearly worsens over time for many people. A longitudinal study tracking 1,555 fibromyalgia patients for up to 11 years found that symptoms worsened in roughly 36% of patients, while only about 25% experienced moderate or better improvement in pain. The overall picture was one of persistently high symptom levels, with a slight trend toward improvement for some but no meaningful average change across the group. About 44% of patients shifted in and out of meeting diagnostic criteria at various points, which reflects how fibromyalgia can fluctuate in severity.
The Four-Class Model of Progression
The closest thing to a staging framework comes from a study that analyzed nearly 80,000 clinical visits across 2,529 fibromyalgia patients. Researchers identified four parent classes that represent increasing complexity and severity. These aren’t formal stages you’ll find on a medical chart, but they describe a real and recognizable pattern.
- Class 1: Regional fibromyalgia with classic symptoms. Pain is concentrated in specific areas, commonly the knees, neck, shoulders, arms, and chest. Common accompanying issues include muscle spasms, spinal arthritis, and interstitial cystitis. This is the earliest presentation, where pain hasn’t yet spread throughout the body.
- Class 2: Generalized fibromyalgia with increasing widespread pain. Pain expands beyond the original regions, spreading significantly into the chest, lower back, hips, and knees. Arthritis and upper body pain become more prominent. Additional symptoms start appearing beyond just pain.
- Class 3: Advanced fibromyalgia with associated conditions. This class involves not only increasing widespread pain but also worsening sleep disturbances, chemical sensitivity, and migraines. The range of affected body regions grows, and conditions like cervical problems and upper body/limb pain layer onto the existing symptoms. This is where fibromyalgia starts significantly overlapping with other chronic conditions.
- Class 4: Secondary fibromyalgia reactive to other diseases. In this class, fibromyalgia develops in the context of another underlying condition such as lupus, multiple sclerosis, irritable bowel syndrome, or temporomandibular joint disorder. Pain tends to center in the chest, and treatment focuses more on the underlying disease driving the fibromyalgia symptoms.
One important nuance: Class 4 isn’t necessarily “worse” than Class 3. It describes a different origin, where fibromyalgia emerges as a secondary response to another illness rather than as a standalone progression.
How Pain Processing Changes Over Time
The biological mechanism behind fibromyalgia’s tendency to worsen involves something called central sensitization. In simple terms, your nervous system becomes increasingly sensitive to pain signals over time. Normally, your spinal cord and brain filter and moderate pain signals so that mild stimuli don’t register as painful. In fibromyalgia, this filtering system breaks down.
What starts as a normal pain response can trigger a prolonged increase in the excitability of pain-processing neurons. Nerve cells that previously needed a strong signal to fire start responding to weaker and weaker inputs. This is why someone with fibromyalgia can experience pain from pressure that wouldn’t bother most people, or why pain that started in one area can eventually feel like it’s everywhere. Changes in the brain’s support cells and in how genes involved in pain processing are expressed help maintain this heightened state, which is part of why the condition tends to persist rather than resolve on its own.
Conditions That Develop Alongside Fibromyalgia
As fibromyalgia progresses, it rarely stays limited to pain alone. The most common conditions that overlap with fibromyalgia include irritable bowel syndrome, chronic fatigue syndrome, tension and migraine headaches, temporomandibular joint disorder, and major depression. Fibromyalgia also frequently co-occurs with hypothyroidism and autoimmune diseases like rheumatoid arthritis and lupus.
Depression and anxiety are especially common and can be severe. These aren’t simply emotional reactions to living with chronic pain (though that’s part of it). The same central sensitization process that amplifies pain signals also affects brain circuits involved in mood and stress regulation. Sleep problems compound everything: poor sleep worsens pain sensitivity, increases fatigue, and makes mood disorders harder to manage, creating a cycle that drives the condition forward.
What Management Looks Like at Different Severity Levels
A 2025 clinical guideline rated all of its fibromyalgia treatment recommendations as strong, emphasizing three pillars: medication, exercise, and emotional regulation. The goals are straightforward: relieve pain, fatigue, sleep problems, and emotional distress, and help you stay active enough to keep doing the things that matter to you.
For medications, the options with the best evidence include pregabalin, duloxetine, milnacipran, and amitriptyline. These work on the nervous system’s pain-processing pathways rather than on inflammation, which is why standard anti-inflammatory drugs like ibuprofen are specifically not recommended for fibromyalgia, either alone or in combination with other treatments. Effectiveness varies significantly from person to person, and finding the right fit often takes trial and adjustment.
Non-drug approaches are equally important, and for some people more so. Aerobic exercise, strength training, and aquatic exercise all have strong evidence behind them. Cognitive behavioral therapy helps identify and change thought patterns and behaviors that amplify pain and stress. Stress management through whatever reliably helps you relax, whether that’s reading, music, or social activity, plays a real role in keeping symptoms from escalating. Because fibromyalgia affects everyone differently and can shift in severity over time, treatment plans work best when they’re personalized and regularly reassessed.
Long-Term Outlook
The honest picture from long-term research is mixed. In the 11-year tracking study, about 10% of patients had substantial improvement in pain and another 15% had moderate improvement. But roughly 36% got worse over that same period. Five-year improvement rates for pain and fatigue were minimal on average, and the overall global severity score showed essentially no change.
What this means practically is that fibromyalgia is a chronic condition for most people, but it’s not a steadily worsening one for everyone. Nearly half of patients in the study moved in and out of meeting diagnostic criteria, suggesting that while the underlying condition persists, its day-to-day severity can fluctuate considerably. Flares and remissions are common. The goal of treatment isn’t typically to cure fibromyalgia but to reduce the frequency and intensity of flares, manage the conditions that pile on over time, and maintain as much function and quality of life as possible.